Back to search

EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS

Data up to Jan 2025

Published1999
Citations529
References66

Total Citations Per Year

Abstract

References (66)

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

1984 • 1,284 citations

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1995 • 1,207 citations

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

1994 • 1,078 citations

Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients

1990 • 947 citations

Orthotopic Homotransplantation of the Human Liver

1968 • 709 citations

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

1988 • 695 citations

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1995 • 596 citations

MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY

1988 • 535 citations

Epstein-Barr Virus Infections and DNA Hybridization Studies in Posttransplantation Lymphoma and Lymphoproliferative Lesions: The Role of Primary Infection

1985 • 470 citations

Non-Hodgkin's Lymphomas

2011 • 466 citations

Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

1981 • 424 citations

EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B CELL LYMPHOPROLIFERATION

1985 • 416 citations

Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management

1993 • 412 citations

Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder

1995 • 391 citations

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

1994 • 373 citations

Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation

1991 • 355 citations

PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1

1998 • 345 citations

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders

1997 • 304 citations

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.

1995 • 281 citations

Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome

1998 • 258 citations

Aggressive treatment for postcardiac transplant lymphoproliferation

1995 • 254 citations

Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease

1995 • 245 citations

Clinical characteristics of post-transplant lymphoproliferative disorders

1994 • 245 citations

Posttransplant Lymphoproliferative Disease in Primary Epstein‐Barr Virus Infection after Liver Transplantation: The Role of Cytomegalovirus Disease

1997 • 241 citations

Five Yearsʼ Experience in Renal Transplantation with Immunosuppressive Drugs

1968 • 237 citations

Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells

1988 • 217 citations

CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS

1996 • 200 citations

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTS

1993 • 188 citations

SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1

1998 • 183 citations

REDUCED INCIDENCE OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER USING PREEMPTIVE ANTIVIRAL THERAPY1

1997 • 181 citations

Epstein‐barr virus‐infected b cells persist in the circulation of acyclovir‐treated virus carriers

1989 • 180 citations

Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation

1996 • 170 citations

Central Nervous System Lymphomas In Organ Allograft Recipients

1995 • 151 citations

Regression of oral hairy leukoplakia after orally administered acyclovir therapy

1988 • 142 citations

CLASSIFICATION OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASES: Implications for Understanding their Pathogenesis and Developing Rational Treatment Strategies

1995 • 133 citations

INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1

1998 • 130 citations

Comparison of Intravenous Ganciclovir Followed by Oral Acyclovir with Intravenous Ganciclovir Alone for Prevention of Cytomegalovirus and Epstein‐Barr Virus Disease After Liver Transplantation in Children

1997 • 122 citations

Therapy for Transplant-Related Lymphoproliferative Diseases

1993 • 121 citations

Posttransplant t-cell lymphoma. Report of three cases and a review of the literature

1994 • 108 citations

AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF EPSTEIN-BARR VIRUS-POSITIVE AND -NEGATIVE LYMPHOPROLIFERATIVE DISORDERS ARISING IN ORGAN TRANSPLANT RECIPIENTS1

1997 • 108 citations

Antiviral prophylaxis and the Epstein Barr virus‐related post‐transplant lymphoproliferative disorder

1995 • 101 citations

Lymphoma of Donor Origin Occurring in the Porta Hepatis of a Transplanted Liver

1993 • 86 citations

Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.

1996 • 81 citations

Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy

1993 • 79 citations

Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation

1996 • 76 citations

TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN THE CENTRAL NERVOUS SYSTEM OF A LUNG TRANSPLANT RECIPIENT USING ALLOGENEIC LEUKOCYTES1

1997 • 73 citations

Epstein‐Barr Virus‐Induced T Cell Lymphoma in Solid Organ Transplant Recipients

1998 • 72 citations

Management of lymphoproliferative disorders after cardiac transplantation

1993 • 59 citations

Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice

1997 • 51 citations

Epstein–Barr virus–driven gene therapy for EBV–related lymphomas

1996 • 49 citations

Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy.

1997 • 46 citations

Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.

1994 • 46 citations

Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus

1985 • 43 citations

TREATMENT OF CENTRAL NERVOUS SYSTEM B LYMPHOPROLIFERATIVE SYNDROME BY LOCAL INFUSION OF A B CELL-SPECIFIC MONOCLONAL ANTIBODY

1992 • 43 citations

Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation

1995 • 39 citations

Post-transplantation T cell lymphoblastic lymphoma

1987 • 36 citations

Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.

1993 • 34 citations

Pseudolymphoma in Renal Allograft Recipients

1978 • 28 citations

Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.

1997 • 26 citations

Sensitivity of Epstein‐Barr virus‐induced B cell tumor to apoptosis mediated by anti‐CD95/Apo‐1/fas antibody

1997 • 25 citations

Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.

1985 • 24 citations

Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.

1997 • 23 citations

PENTOXIFYLLINE DOES NOT PREVENT THE CYTOKINE-INDUCED FIRST DOSE REACTION FOLLOWING OKT3-A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY1,2

1996 • 21 citations

Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis.

1991 • 19 citations

COMPLETE REMISSION AND POSSIBLE IMMUNE TOLERANCE AFTER MULTIDRUG COMBINATION CHEMOTHERAPY FOR CYCLOSPORINE-RELATED LYMPHOMA IN A RENAL TRANSPLANT RECIPIENT WITH ACUTE PANCREATITIS

1991 • 14 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (1999) – Transplantation | Metascience Observatory Explorer